STADA Arzneimittel AG SWOT

• Publication date: December 2011

examines the firm ’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. STADA Arzneimittel (STADA), through its subsidiaries, develops and industry s products with off-patent active pharmaceutical redients (APIs). It also provides over the counter (OTC), non-prescription and prescription drugs. The group operates in Europe, the Americas, Africa and Asia. It ...

examines the firm ’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

STADA Arzneimittel (STADA), through its subsidiaries, develops and industry s products with off-patent active pharmaceutical redients (APIs). It also provides over the counter (OTC), non-prescription and prescription drugs. The group operates in Europe, the Americas, Africa and Asia. It is headquartered in Bad Vilbel, Germany and employed 8,064 people as of December 31, 2009. The industry player recorded sales of E1,568.8 million ($2,187.9 million*) during the financial year (FY) ended December 2009, a decrease of 4.7% over FY2008. The operating profit of the industry player was E191.9 million ($267.6 million*) during FY2009, a rise of 8.8% over FY2008. The net profit was E100.4 million ($140 million*) in FY2009, a rise of 31.8% over FY2008. * Calculated using the constant conversion rate of E1 = USD 1.39463 for the financial year ended December 31, 2009.

What's Included In This Report?

- Provides all the crucial information on STADA Arzneimittel AG required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting STADA Arzneimittel AG in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of STADA Arzneimittel AG
-Data is supplemented with details on STADA Arzneimittel AG history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from STADA Arzneimittel AG

Why Should You Buy This Report?

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date industry player information available

Prescription Drug Industry in Germany

Table of Contents:

SWOT COMPANY PROFILE: STADA Arzneimittel AG
Facts and Figures : STADA Arzneimittel AG
Corporate Description : STADA Arzneimittel AG
Business Overview : STADA Arzneimittel AG
Company History: STADA Arzneimittel AG
Top Executives : STADA Arzneimittel AG
Resumees : STADA Arzneimittel AG
Business Lines (products and services) : STADA Arzneimittel AG
Products & Services Analysis: STADA Arzneimittel AG
Strategic analysis (SWOT) : STADA Arzneimittel AG
*Strengths: STADA Arzneimittel AG
*Weaknesses: STADA Arzneimittel AG
*Opportunities: STADA Arzneimittel AG
*Threats: STADA Arzneimittel AG
Company View: STADA Arzneimittel AG
Competitive Landscape : STADA Arzneimittel AG
Subsidiary : STADA Arzneimittel AG
*Head Office: STADA Arzneimittel AG
*Other Locations and Subsidiaries: STADA Arzneimittel AG

Prescription Drug in Germany

Germany Prescription Drug Sales, Us$bn

• $ 250
• Industry data
• January 2013

Yearly, From 2002 To 2021
By Business Monitor International
Source: German Association of Research-based Pharmaceutical Companies (VFA), IMS Health, German Association

• Industries : Prescription Drug
• Countries : Germany

Germany Prescription Drug Sales, Us$bn, % Chg Y-o-y

• $ 250
• Industry data
• January 2013

Yearly, From 2003 To 2021
By Business Monitor International
Source: German Association of Research-based Pharmaceutical Companies (VFA), IMS Health, German Association

• Industries : Prescription Drug
• Countries : Germany

Germany Prescription Drug Sales, Eurbn, % Chg Y-o-y

• $ 250
• Industry data
• January 2013

Yearly, From 2003 To 2021
By Business Monitor International
Source: German Association of Research-based Pharmaceutical Companies (VFA), IMS Health, German Association

• Industries : Prescription Drug
• Countries : Germany

Germany Prescription Drug Sales, Eurbn

• $ 250
• Industry data
• January 2013

Yearly, From 2002 To 2021
By Business Monitor International
Source: German Association of Research-based Pharmaceutical Companies (VFA), IMS Health, German Association

• Industries : Prescription Drug
• Countries : Germany

Germany Prescription Drug Sales, % Of Total Sales

• $ 250
• Industry data
• January 2013

Yearly, From 2002 To 2021
By Business Monitor International
Source: German Association of Research-based Pharmaceutical Companies (VFA), IMS Health, German Association

• Industries : Prescription Drug
• Countries : Germany